Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Post by Trippedstockson Oct 26, 2021 10:11am
193 Views
Post# 34049283

So it still doesn't do anything?

So it still doesn't do anything?
Told you, No safety concerns, next update Feb.

The market doesn't care for MF's false promises. The July PR said 600 and 800 expected end of Q3 wasn't it? Now 800 end of Q4!?. Most likely early feb of Q1-2022.

The only people who read his releases are people already invested. No one cares about zero results and false, always extended, deadlines. That's why virtually zero change in SP.

perhaps Dr. Fahy is finally going to put something in a test tube again and we may see some kind of results from that by Christmas.

I expect 50%-60% efficacy at the most now, as other DSMB unblinded other studies for that. If it was better(80-90%), they would most likely had unblinded here. Unless we have requested to continue for the viral load factor

5 billion pills for what? Not a single government or health agency even knows about this drug. They aren't even prescribing the other EUA covid treatments in the USA. Why would we get priority over the billions the US government already spent on monoblahblah injections?

The sad part is we'd all make more investing in Trump
<< Previous
Bullboard Posts
Next >>